Holding(s) in Company

RNS Number : 4381E

CVS Group plc

06 April 2011

 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:		CVS Group Plc
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights			YES
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) subject to notification obligation:	North Atlantic Value LLP  (as investment adviser/manager)
4. Full name of shareholder(s) (if different from 3):	1. Oryx International Growth Fund Limited 2. North Atlantic Smaller Companies Investment Trust PLC
5. Date of transaction (and date on which the threshold is crossed or reached if different):	5 April 2011
6. Date on which issuer notified:	6 April 2011
7. Threshold(s) that is/are crossed or reached:	Through 10%

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
Ordinary shares Sedol: B286382 Holder 1       3,750,000      3,750,000      3,750,000    3,750,000                            6.64% Holder 2      1,852,500      1,852,500      1,909,932     1,909,932                            3.38%                                                                                       TOTAL:                      10.02%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights

Total (A+B)
Number of voting rights	Percentage of voting rights
5,659,932	10.02%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Not applicable

Proxy Voting:
10. Name of proxy holder:	-
11. Number of voting rights proxy holder will cease to hold:	-
12. Date on which proxy holder will cease to hold voting rights:	-

13. Additional information:	North Atlantic Value LLP is the investment manager/adviser in respect of the full 10.02% holding as it is investment adviser to Holder 1 as well as Joint Manager of Holder 2.
14 Contact name:	Bonita Guntrip
15. Contact telephone name:	020 7747 5681

For notes on how to complete form TR-1 please see the FSA website.

 

END

 

 

HOLLLFVSSFIRIIL